IPSC

1.16511.74%
CA

Chad A. Cowan

Chief Scientific Officer

Dr. Chad A. Cowan, Ph.D., is Director of Somite Therapeutics, Inc. Dr. Cowan joined the Somite Therapeutics, Inc. in 2025. Dr. Cowan has served on the board of directors of Somite AI since September 2024. Dr. Cowan founded and served as Chief Scientific Officer of Sana Biotechnology, Inc., from July 2018 until October 2019. Dr. Cowan is Scientific Founder of CRISPR Therapeutics, Inc. Dr. Cowan is Chief Scientific Officer of Century Therapeutics, Inc. from October 1, 2024. Dr. Cowan is a Co-Founder, Chief Executive Officer, Treasurer, Secretary & Director at Clade Therapeutics, Inc. He served as Vice President at D.A. Davidson & Co. Dr. Cowan is Scientific Founder of CRISPR Therapeutics AG. Dr. Cowan served as Head of Research at CRISPR Therapeutics, Inc., from May 2015 until May 2017. Dr. Cowan is an Associate Professor at Harvard University in the Department of Stem Cell and Regenerative Biology and at Massachusetts General Hospital, with appointments in the Center for Regenerative Medicine, the Cardiovascular Research Center and the Center for Human Genetics Research. He was named a Stowers Medical Investigator in 2006 and has been faculty member at Harvard University since 2008. He serves as a Member of Scientific Advisory Board at Metagenomi Therapeutics, Inc. (formerly known as Metagenomi, Inc.) He is an associate member of the Broad Institute and a principal faculty member of the Harvard Stem Cell Institute, where he directs the Diabetes Disease Program and the iPS Cell Core Facility. He has led or been a member of several large efforts to use stem cells to better understand disease, including the National Heart, Lung and Blood Institute’s Next Gen iPS Cell Project and the Progenitor Cell Biology Consortium. More recently, he has focused on using genome editing tools as therapeutics. He has also played an early role in the launch of several gene and cell therapy companies including, BlueRock Therapeutics, Vesigen Therapeutics and Vita Therapeutics. He was employed at UBS. Dr. Cowan served as a Member of the Scientific Advisory Board of iPierian, Inc. He received his BA and BS, with honors, from the University of Kansas. He received his PhD from the University of Texas Southwestern at Dallas, garnering the Nominata award for most outstanding thesis. In 2008, he became a Professor at Harvard University, Harvard Medical School and the Harvard Stem Cell Institute, where he led academic research groups and taught. Dr. Cowan has B.S. from University of Kansas. He subsequently completed a Damon Runyon fellowship with Professor Douglas Melton at Harvard University.

Positions